Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Do we see .15 again first half of 2015?
No doubt, a totally useless person - just an additional unpleasant cost factor which could be avoided easily.
Sorry, IMO never! My hopes for 'bucks' are gone, I wait for .50 - .70 - still happy to speculate with free shares. But the chances to make money with PLPL are melting rapidly after this latest news. PLPL does not deliver real hopes in revenuees ....especially after they did release they want $ 25.000.000 by dilution. This is the typical dirty game by pennie managenments - but here even worse as Duffiled did promise some days before zero dilution. He is one of the worst liars I have noticed since long at the OTC. It was a mistake to invest here - it is nothing but a dirty pennyplay which should be sold with the one big hype pennies always see in their 'carrer' and than....forget it. This story stinks meanwhile - same smell which I remember since years.
Did you all notice: NOTHING at all anymore by Shively ! Still no new partners, companies, cooperations? Just always the same crap about clinical researchs, trials, etc. etc.? A wonderful biotech-trick to keep shareholder hoping and believing.
They can't be real because PLPL is just a f...g untrustworthy tiny pennystock at the OTC - one of thousands - used by some fishy unknown business people to make big money by screwing those who try to make some money with speculation. The reason why those guys make such big money is..... because we are too stupid to do big money by ourselves and trust in people whom we do not know and in words which can not be proved to be true - but we nevertheless are still thrilled by any good sounding news release. This is well known by leaders of listed pennystocks and this is why we will always be cheated.
I should have sold all at 1.00.... but this I say since ten years
CEO Duffield - a big liar?
9th of January: " "But, from a practical standpoint, now that the factory is opened, we can start generating revenues and positive cash flows. This will allow us to operate without dilution or incurring additional debt, expand our products lines, and return value to our shareholders." (see source below)
21st of January: Offering shares for $ 25.000.000 for approx. $ .27 = approx. 100.000.000 shares dilution !!!!
This CEO doesn't seem to be trustworthy at all - it took him 12 days only to do the opposite of what he promised. With my words: PLPL might appear to be a big lie and in fact this latest file is a clear sign of NO revenuees in 2015 - again same like 2012/2013/2014 - and, not to forget: Duffield promised tons of reveneues for 2013 already...and...in fact the truth: nothing has been earned!!!. There is nothing to come in my opinion anymorfe by PLPL but only robbery by management of PLPL! I do not believe Duffield one word anymore !
Plandai Biotechnology, Inc.'s CEO Discusses Company's Plans for 2015
Marketwired
Plandai Biotechnology, Inc. January 9, 2015 9:00 AM
NEW YORK, NY--(Marketwired - January 09, 2015) - Plandaí Biotechnology (PLPL) recently updated shareholders on a list of accomplishments reached in 2014, so Stock Market Media Group (SMMG), a research and content development investment relations firm, spoke with Plandaí's Chief Executive Officer, Roger Duffield, to discuss Plandaí's plans for 2015.
SMMG: First and foremost, can we get your reaction to the opening of your new production facility in South Africa and what does its completion mean for Plandaí in 2015?
Roger Duffield: "Well, opening the Senteeko facility is really the culmination of over a decade of research, sacrifice, and determination. Taking the initial concept that we could produce a highly bioavailable plant extract -- at a time when no one was even looking at the importance of bioavailability for nutraceuticals -- and then seeing it through to this point, has been an amazing journey that wouldn't have happened without the help and support of countless people. I get chills every time I visit Senteeko, drive thirty minutes on logging roads through thick forests, and then pass the gates to our estate and see the vast acres of tea with this amazing jewel of a factory sitting in the middle. I'm overwhelmed, excited, relieved, and deeply humbled all at the same time."
SMMG: What is the significance of Plandaí's shift from a research and development company to a biotech that produces and sells products?
Roger Duffield: "Let me answer by first stating that Plandaí will always be a research and development company. When you look at the pharmacopeia of medicinal plants, you can see that there are hundreds of potential future research products for us. And even with just green tea catechins, we could spend a lifetime just on different human clinical trials as we explore the vast potential of this amazing plant.
"But, from a practical standpoint, now that the factory is opened, we can start generating revenues and positive cash flows. This will allow us to operate without dilution or incurring additional debt, expand our products lines, and return value to our shareholders.
Related Quotes
"Operationally, it means that we now have a whole new business model with new logistics. When you stop to think about what it takes to sell a product like Phytofare®, it requires so many moving parts working in harmony. Growing the leaf, picking it properly, manufacturing, batch testing, packaging, tracking and quality control, shipping, customs. Then you have the sales aspect, which includes marketing, trade shows, literature. It's really quite a process that I think few people fully understand."
SMMG: In 2013 Plandaí announced its entrance into the cannabis research arena, in 2014, the company secured a licensing agreement with Diego Pellicer and then obtained a consent letter from the Minister of Health in Uruguay to begin growing cannabis and producing an extract for animal testing, so what can we expect in 2015?
Roger Duffield: "Our plan at this point is to establish the cannabis growing infrastructure in Uruguay this year with an expectation of having an extract ready for testing six to nine months after it comes online. Our initial goal of having a product market-ready by the end of 2014 proved unrealistic once we determined that current U.S. laws, even in states where marijuana is legalized, prohibited us from legally acquiring cannabis, producing an extract, and then testing it inside the U.S.
"Our operation in Uruguay will allow us to better control the chemical profile and then conduct our research into various neural disorders in a safe, legal, and scientifically validated manner. Also, we will be able to establish standards for dosage and chemical profile, which has so far been very limited with respect to cannabis research."
SMMG: After releasing the data in 2014 from a human clinical trial performed at North West University in South Africa that showed Plandaí's Phytofare® Catechin Complex demonstrated ten times greater bioavailability over a generic catechin extract, what is next in the on-going research at North West University?
Roger Duffield: "Starting this month, the research team at North West University in South Africa, under the supervision of the Dean's office of the Faculty of Health Sciences and the inventor of the Pheroid® delivery system, Prof. Anne Grobler, will complete the third arm of the bioavailability study. This final phase will use the same 26 human subjects, but this time the study will incorporate the addition of Pheroid® to the Phytofare® extract.
"We anticipate that adding the Pheroid® delivery system will increase the overall bioavailability while also opening up the potential to use our extracts in less controlled applications such as adding Phytofare® to other ingredients including topical creams and liquids, and in environments where you are less able to control exposure to outside influences such as UV light, which kills the antioxidants.
"North West University will also be conducting our human weight loss clinical trial, which will test the Phytofare® versus a placebo over 90 days and involving 120 patients. This trial will also be looking at a complete blood panel so we can identify from a medical standpoint the effects of catechins on everything from blood sugar to cholesterol. The results could potentially open entirely new fields of research."
SMMG: Any closing thoughts?
Roger Duffield: "2015 promises to be a productive year for Plandaí. With the completion of the new laboratory inside the Senteeko facility, we plan to produce our first citrus extract and then test its bioavailability followed by a human clinical trial to confirm improved respiratory benefits including symptom relief for sinus, colds and the flu. And, as always, we continue to explore the medical potential of other phytonutrients and expect to test new extracts throughout the year."
About Stock Market Media Group
SMMG is a Research and Content Development IR firm offering a platform for corporate stories to unfold in the media with research reports, CEO interviews and feature news articles. SMMG is compensated $3,500 per month by Plandai Biotechnology for content development. Previously, SMMG was compensated for similar content by a third party which occurred from April 2013 through June 2014. During that period, SMMG received approximately $55,000 for its content. Neither SMMG nor anyone associated with it owns shares in PLPL. For more information: www.stockmarketmediagroup.com.
In 2015: $0 revenues = $ 25.000.000 dilution?
Does Duffield intent to fill his pockets heavily? Have latest news release been released only to catch investor to invest those $ 25.000.000 ?
Does PLPL dilute because revenues are not in sight ???
News Jan 21st: 100.000.000 shares dilution ????????
PLANDAÍ BIOTECHNOLOGY, INC.
$25,000,000
COMMON STOCK
"This prospectus relates to the offer and sale of shares of common stock, par value $0.0001, of Plandaí Biotechnology, Inc., a Nevada corporation, having a maximum aggregate offering price of $25,000,000."
http://ih.advfn.com/p.php?pid=nmona&article=65185949&symbol=PLPL
If this will be dilution, I will be out as PLPL will go .10 ! AND this would be the biggest lie of Duffield who promised NO dilution!
Well, news releases of PLPL always sound very good and promising - but long term shareholder are not that much inmterested in great news anymore if this news does not also content details of sold products.! News can be produced en mass - in the opposite to revenues.
So I start to be neutral towards any news which say, "we do this and that, and we arew greast in this and that.....but we can not say anything about sales future, business partners, wholeseller, growth, deliverable products, etc. "
But, hey, watch the shareprice....I am not the only one who start to doubt
that PLPL will ever deliver anything more that 'great news'....have seen too many microcaps did the same, but nothing else. As long as Duffield does not prove his ability to keep the company alive without loans and dilution, as long this story is a wind bag or one of those hundreds of pennystocks use by its directors for personal business reasons - carried ouit on the shoulder of anonymus shareholder.
However, still hoping this story is real.
NEWS: Plandai Biotechnology to Use "Trojan Horse" to Make Highly Bioavailable Products Even Stronger
NEW YORK, NY--(Marketwired - January 20, 2015) - Plandaí Biotechnology (PLPL) proved in a bioavailability study performed at North West University in South Africa, that its green tea Phytofare® Catechin Complex demonstrates ten times greater bioavailability over that of a generic catechin extract. Bioavailability is a fancy word for how much of the dosage of a drug or substance like Plandaí's extract gets absorbed into our bloodstream so it can actually be effective. The three-part human clinical trial proved in part two of the study that all 8 catechins that make up the green tea plant made it into the bloodstream of the 26 participants, and those catechins stayed in the bloodstream 5 times longer than the generic extract that Plandaí's product was compared to in the study.
Now imagine taking a product that demonstrates it is highly bioavailable and then making it even stronger. That is Plandaí's plan with the addition of the Pheroid® delivery system. Think of the Pheroid technology, developed by Professor Anne Grobler at North West University, as a "Trojan Horse" sneaking Plandaí's highly bioavailable extract even deeper into the human body, not just into the bloodstream, but into our cells.
We've all heard of the many benefits that the green tea plant provides, but those benefits can only be realized if the catechins that make up the plant can get into the bloodstream and stay there long enough to be effective, and now Plandaí is talking about potentially making the benefits of green tea even more powerful by delivering the company's extract right to the cells of the human body.
This month Plandaí expects to begin what will be the third arm of the three-part human clinical trial. The research team at North West University, under the supervision of the Dean's office of the Faculty of Health Sciences and Prof. Anne Grobler, will complete this third arm of the bioavailability study. This final phase, which will use the same 26 participants as parts 1 and 2, will incorporate the addition of Pheroid to Plandaí's Phytofare extract.
Plandaí Biotechnology's CEO, Roger Duffield, said of the addition of Pheroid, "Pheroid is an amazing delivery system that protects the entrapped Phytofare from damage. When dealing with nutraceutical ingredients and additives, small things can have a huge impact on viability. Exposure to heat, light, and air during the processing and storage can affect the potency. Other ingredients, such as sugar, water, preservatives and the like can neutralize the active properties. And the digestive process itself is designed to break down and metabolize the catechin molecules, potentially ruining their efficacy."
So what makes Pheroid the ideal way to deliver Plandaí's extracts into the cells of the body? Pheroid uses a long-chain Omega-3 and Omega-6 fatty acid system to entrap the company's Phytofare at the mainly nano level. Our white blood cells perceive the fatty acids as a food source and bring them inside the cells, where the process of glycolysis dissolves the Pheroid and releases Phytofare. This will increase Plandaí's ability to deliver active ingredients directly to the cells.
Duffield added, "Using Pheroid allows us to expand the potential applications of Phytofare. The protective barrier provided by Pheroid gives customers the ability to add it to a host of different ingredients that would otherwise impact the product's efficacy. Pheroid's protective properties also mean that customers have greater flexibility in their manufacturing and packaging. Finally, from an application standpoint, using Pheroid opens the door for both topical and liquid oral products."
Having a Pheroid alternative for Plandaí's customers opens a host of additional product options for the company. For example, topical creams and liquid oral products are ideal for Pheroid as it protects the Phytofare and also facilitates absorption. (Pharmaceutical applications of Pheroid technology / Anne F. Grobler Abstract 2009: http://hdl.handle.net/10394/6701) Duffield said that the company's customers can then also add ingredients such as flavor enhancements, fragrance, coloring, or other active ingredients without causing interactions that could neutralize Phytofare's effectiveness.
About Stock Market Media Group
SMMG is a Research and Content Development IR firm offering a platform for corporate stories to unfold in the media with research reports, corporate videos, CEO interviews and feature news articles. SMMG is compensated $3,500 per month by Plandai Biotechnology for content development. Previously, SMMG was compensated for similar content by a third party which occurred from April 2013 through June 2014. During that period, SMMG received approximately $55,000 for its content. Neither SMMG nor anyone associated with it owns shares in PLPL. For more information: www.stockmarketmediagroup.com.
Contact:
Stock Market Media Group
info@stockmarketmediagroup.com
Obvioulsy words of CEO Duffield do not count anymore. But I am sure Duffield does not care about the shareprice- otherwise they would have done development different - at least I would have done it different.
1. I would have done a better research about effect of Phytofare BEFORE going public - 2. I would have asked a person like Shively to involve in my company with an effect and not just with his name otherwise this guy has no right to receive options, shares, salaries, etc.for free etc.etc.etc.
But the worst point is: Duffield destroys confidence as we all do not know if he just talks since years or if he will deliver anything ever. Photos of a half ready facility does not produce confidence for years !
But, as I said, maybe Duffield has other plans as most of penny CEOs have - and which are 99% not in the interest of shareholder.
We will see how the next 10 Q looks like - without revenues again of course!
Last time they sold timber to make some thousand $ - maybe this time PLPL sells potatoes to the african markets?!
I think it would be nonsense, even a lie if Duffield talks about avoidance of dilution in 2015 if on the other hand PLL would not make any revenues in 2015. If Duffield think shareholder have endless patience and believe endless in CEOs words, he will be totally wrong. PLPL would no be the first pennystock which has died by lies. But in one thing Duffield is totally right: It takes enormous time to make a new company running until revenues will be made. So my problem is only: If it takes more time... but without dilution - I am able to keep my confidence. But zero reveneues and millions of dilution - I would be out as this would prove the worst case of a scam. BUT we are not yet there !!!!!!!!!!!!!!!!
Wow, great DD ! Thanks a lot ! Pleased to see that JGLD is still alive. Will see what I decide. Difficult for me as I lost approx. $120.000 since last two years with those pennies which promised a lot and did not keep anything. But, yes, my fault, stop loss would have been the right decision and not keeping till death. I am not a daytrader or weektrader as running my company demands a lot of care. Fortunately it is not a pennystock
Again, great find! Will think about it.
Sorry, but you did not read well: "........... from a practical standpoint, now that the factory is opened, we can start generating revenues and positive cash flows. This will allow us to operate without dilution or incurring additional debt, expand our products lines, and return value to our shareholders. "Operationally, it means that we now have a whole new business model with new logistics. When you stop to think about what it takes to sell a product like Phytofare®, it requires so many moving parts working in harmony. Growing the leaf, picking it properly, manufacturing, batch testing, packaging, tracking and quality control, shipping, customs. Then you have the sales aspect, which includes marketing, trade shows, literature. It's really quite a process that I think few people fully understand............"
Well, if Plandai does not make some millions of revenues this year, shareprice will drop into the mud as confidence will die. There are thousands od microcaps out there which promise for years to make revenues and finally they never deliver anything but words.
I stay in Plandai with free shares, but I do not accumulate anymore. Duffield talks too much without any real monetary value since yaers.
Butter and bread = fiction and reality = promises and revenues = if you keep butter too long...it melts or stinks!
Tax write off 2015 already? Boring chart and nervwrecking. I think people do not like PLPL...they just use it for making some $$ by this volatility. Well, understandable - pennystocks are just made for this 'trustless' kind of 'investing'
Shareholder have been holding longterm and have been "eating" each news release - no update neceessary - and at least: nothing new....so it is not an update as it is only a endlyess repetitions of things which have been said again and again.
But I miss: still no revenues, no words anymore by or about Shively, no deadlines neither for revenues nor clinical results nor first deliveries of products, nor about new business partners etc.etc.etc . just always the same blahblah one can listen to from every penny CEO "We are progressing well" - Have been reading such "updates" thousands of times within 20 years of penny specultaion!
Bullstocks, Santa is dead from the neck up and will bring Herzog another jailfree year as Santa does to 99% of penny CEOs. Santa is a payed friend of the bad - and he lets the poor stay poor - and he punishes the ugly. Thats our wonderful world -with or without Santa !
LAST MAN STANDING - thats my feeling here
Good luck to all in 2015 !
However: At least last days can be taken as a little christmas gift for all shareholder - anyway a very rare gift by pennystocks directly at 23rd of december.
In this case....... a Merry Christmas .... and maybe a Merry Bottom
Easy come, easy go. Guess we have seen a little hiccup, but maybe a bottom will be formed at .30 as some might keep shares now more tight, On the other hand, if some did miss the news and the 'hiccup'they might sell till 31st. However, this hiccup confirms that people still focus on PLPL .... and this is the most important 'information' end of 2015 !
Guess this comment goes to fare as PLPL might be worth a lot of critics - but for shure it is not a Zombie stock.
As I do not want to sound negative again - I give up to comment this news as I did this since months - I would have to repeat myself endless...............
Mayby Duffield intent to give a bit of christmas feeling to shareholder after a year of hell feeling.
If .25 forms a bottom, I would be happy: This could help for a rebound to .35 in January and .40 - .45 in February before 10Q.....COULD be, just a hope.
Easy to explain: It was just a try by some people. I am sure investor have not been interested in such a tiny gold play and so the 'management' gave up cause of lack of interest and as they did not intent to inevst money by themselves as well - maybe they also have been fightimng internal - for or against whatever. This gold play was a jokle anyway from the vryginning - no-beginning LOL One can't fool markets too often anymore.
BTW, the website is down approx. 2-3 weeks
I assume, this shell will be back in some years again with another try to cheat stockmarket member.
GLTU
Gues we will see this a while: Whenever someone wants in, another one wants out and puts the price down again. So, no change this year to see PLPL higher.
On the other hand: Daily volumes are not that high, a lot of holder in here still adn some really pick at this price. Would be nice to see some short squezze in early spring after a useful news release and some confidence coming back before first 10Q. But in this case first report in 2015 should show some reveneues otherwise PLPL could drop like a stone. Duffield is playing a very risky game with 'his' PLPL story. It could end as bad as it has been starting nicely. But this is the price for a CEO with a big mouth - well, which penny CEO doesn't have a big mouth - they are all the same poor entrepeneurs who try to make money by squezzing stockmarket member with their lousy characters.If they would try to make money with a 'real' company, they are going to lose from the very first moment they start.
However, above price scenario is only a hope of mine.
HH does christmas with his family and laughs about us.
By this dynamic we fast will see old lows again. well, Why do I wonder.....this is exactly how penny companies move which have managements with big mouths, big promises without substance and eyewashing promoters.
My worry:
.15 - .20 at the end of 2015
.20 - .25 in early spring 2015
.25 - .30 in late spring 2015
and than...either .50 or.....death of the story.
Duffield has been wrong: Not 2014 will be the year, it will be 2015 as a very last chance for Plandai.
I am with you, celtic! But you must not wait for an irish fairy: I believe Plandai will have a come back - but not as a christmas miracle as you are hoping for. But any tiny revenue in 1st quarter 2015 - will I am STILL hoping for - with help the stock. 1.38 - well, that is not a pleasing enterance PLPL, but even I am not positive about PLPL currently, I still believe market will react to any positive news etc. by and about PLPL. But 2014 will end bloody, even at .25 or worst case .20 - as it has been bloody already, for you alreaqdy for example. But for sure PLPL is not dead yet !!!
My best wishes for you!
If chart technique would be usefull here, I would say: long term resistance broken today, way open down to prices of september 2014 and january 2014 - which would mean... nothing left of all the confidence in spring 2014. Down trend dynamic increases as I predicted - unfortunately. Not sure if I average down based on this lousy news flow, boring Shively and no reveneues again all 2014.... as Plandai said '2014 - the year it happens" . Well I believe the only thing that happened was the increase of salaries. Pennystock treasure robbery as usual by directors and CEO.
Little curious:
Anybody still here who bought higher - or still 99% of the 2013/2014-shareholder gone?
Since PLPL has been founded NOTHING happened which proves(!) that Plandai has a product which could make revenues. Everything publish has been done by Plandai - and can not be proved !
I worry the book Plandai opens a bad side next year and shows just another OTC penny scam.
i'm sure you'll find no real office there, just a rented room with a postbox. And you do not get anybody of Plandai by using any phone number.
I assume they use totally different and private phone numbers for companies phone calls. They are not interested in contacts with all shareholder who bought their shares by stockmarket. The official phone numbers are fake in my opinion. I even undersatnd this: Why talk to shareholder? For PLPL durectors a waste of time. Either you believe in PLPL or not, they do not care.....cause THEY know how to make money with PLPL, why shall they be interested that you win or lose? They want you to buy to receive loans, support, etc. to make everybody believe that this is a real company. As long as this works fine, SEC does nopt has to wonder and directors of PLPL can do money fishing.
Pennystock market is a ultra big fake and people who want to find the next Microsoft prefer eyewash insteed of reality.
In my opinion pennystock speculation should be forbidden! But this, on the other hand, does not fit the worlds greed for money.........
Typical for pennystocks. But I assume Plandai doesn't need a bureau at the States at all- just cause to declare PLPL to be a US company and cause the OTC-listing in the States. I think Plandai bureau is somewhere else in South-Africa or who knows wherever , not really in Utah.
Compared to 2013 and beginning of 2014, news releases are so thin that Plandai seems to be nearly dead.
I worry shareholder will have the worst christmas with Plandai since its listing. Pity - but...well, nothing special as Plandai did developed into pennystock garbage as usual.
I am still amazed, that Plandai deleted theri website blog. Not a good sign as for me this mean, Plandai has nothing anymore to blog, nothing to release, nothing the say.
Scary chart this month. Not sure if all december there will by buyers to pick those shares which are thrown into the market at the end of the year . Could be some hundreds of thousands finally cause tax reasons.
I do mistrust vice president Jamen Shively. Anyway, never trust a pennystock director just because he has been a director of a famous listed company in the past.
Shively has been a no-name-director at Microsoft. This strange reputation did put sand into the eyes of PLPL shareholder. Finally it is clear....Shively has nothing to say and due to this has no value for Plandai. He did NOTHING within nearly one year for Plandai. What shall this company do with such a vice president? Just for wasting salaries!
Guess it is time for him to leave PLPL and Plandai might safe some money for an active vice president.
As I predicted.... dynamic of tendence for downtrend increases in december. Pity, a years end rallye into the wrong direction. But this was to be forseen. Would not wonder if 2014 ends with .25. Guess not lower as big bunchzes of shares will always be bouight by those who believe in PLPL in 2015. The last hope here.
By the way, when does vice president Shively leave the ship? Not too long anymore he will be director, right? Well, he didn't move his a&& for 1 millilmeter anyway for PLPL. Waste of salaries for this looser.
Right....and that's what I was wondering about since a while: Plandai promises delivery and revenues - but is still not ready with delivery of clinical results. The 'style' Plandai does biotech business and promises sales of biotech products has in this case not much to do with seriousness. I do not wonder at all that a lot of stockmarket members do not trust Duffield, PLPL directors and the story. Until today this company, after ten year un-listed and more than two years listed, did not prove at all if there is anything real in this story....photos of facilities can be faked
easily, Uruguay doctors for clinical research can be found easily etc. ....until today nothing is official, neither in the USA nor in Europe. Why? Easy to explain: Because the demands and laws of those governments are so strict that Plandai and its products might not be able to get throw those controls.
As we will not receive anything nice at the end of 2014 - reports will show AGAIN not revenues - we onbly can finally hope for the report of the 1st quarter 2015. If this report does not show any significant revenues again , than Plandai - for me - seems to be a scam.
I really hope I will be wrong !